跳至主要内容
临床试验/NCT05488444
NCT05488444撤回2 期

A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家开始时间: 2022年8月25日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
General Self-Efficacy (GSE) Scale Questionnaires

研究概览

简要总结

Project Lets start will provide individual support to breast cancer patients with the goal of reducing delay to chemotherapy initiation. In this study participants will identify areas of need and work with patient navigators who will provide weekly 1-1 support throughout patient's journey to beginning chemotherapy

详细描述

OBJECTIVES:

Among patients with early-stage breast cancer, delays with the administration of chemotherapy significantly reduce its benefit. Interventions aimed at reducing TTC have the potential of improving outcomes and reducing health disparities. In this study we propose to develop an effective targeted intervention that is culturally sensitive and that addresses the roots of chemotherapy delay.

Our objective is to conduct a pilot study randomizing patients with breast cancer, in whom adjuvant or neoadjuvant chemotherapy has been recommended, to a culturally sensitive and patient-specific targeted intervention using patient navigators or routine clinical care

Primary Aim: To establish feasibility and acceptability.

We hypothesize that the intervention will be feasible and accepted by participants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • I. At least 18 years of age. II. Diagnosis of primary invasive breast cancer. III. Chemotherapy (adjuvant or neo-adjuvant) recommended by treating physician (including pregnant women in 2nd or 3rd trimester).
  • IV. Patient of the University of Texas MD Anderson Cancer Center or planning on receiving treatment at our Institution.
  • V. Can speak, read, and understand English and/or Spanish. VI. Participant can provide consent for themself

排除标准

  • I. Hospitalized for a critical condition or who are considered medically unstable by their medical team.
  • II. Patients that have been previously treated with chemotherapy.

结局指标

主要结局

General Self-Efficacy (GSE) Scale Questionnaires

时间窗: through study completion and average of 1 year.

Responses are made on a 4-point scale, ranging from 1 (not at all true) to 4 (exactly true). Scores could range from a composite score of 10 to 40, with higher score indicating more self-efficacy.25

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验